A guide for the question behind the name.

You may have arrived looking for a company called NextGen Peptides. You may have been looking for retatrutide or trying to tell similar peptide names apart. There is no medicine for sale here.

NextGen is not affiliated with any company that has used the name NextGen Peptides or Next Gen Peptides.

The generation ladder is our way to explain one, two and three receptor targets. A receptor is a part of a cell that receives a signal. The ladder makes a design easier to read. It is not a ranking or a recommendation.

We separate the identity of a compound from the status of a product. FDA is short for the U.S. Food and Drug Administration. FDA-approved semaglutide and tirzepatide products exist. Compounded versions are not FDA-approved. Retatrutide is investigational, not FDA-approved and not available by prescription.

Compounded means made to order. Investigational means still being studied. Those words matter when a research headline and an online sales page use the same compound name.

This guide gives no medicine instructions or personal medical advice. It makes no promises about outcomes. Research-only sellers are not listed or recommended. A licensed provider decides whether care is appropriate.

NextGen may earn money when readers become Promise patients.

That financial relationship is shown beside our first linked invitation on each page and again below. A link is not a review of your health, a prescription or a promise that anyone qualifies.

Promise prescribes semaglutide and tirzepatide now through licensed U.S. providers. A provider reviews every request and decides whether to prescribe. Not everyone qualifies.

Promise is for U.S. patients only. Availability varies by state and by treatment.

Promise has no retatrutide product. Its links here are for metabolic support, semaglutide or tirzepatide. They are not a route to retatrutide.